ZAEEM's BLOG

US FDA gives green light for thyroid cancer drug lenvatinib The Pharmaceutical Journal , 19 FEB 2015 Source: BSIP SA / Alamy US patients with certain forms of thyroid cancer can now benefit from a new drug developed by Eisai after the US Food and Drug Administration fast-tracked its approval  The US Food and Drug Administration (FDA) has fast-tracked the approval of lenvatinib (Eisai’s Lenvima) to treat specific patients with progressive differentiated thyroid cancer (DTC). Lenvatinib, a kinase inhibitor, has been approved as an orphan medicine for patients whose DTC has progressed despite radioactive iodine therapy (radioactive iodine refractory disease), the FDA announced on 13 February 2015. A spokesperson for Eisai says that, based on manufacturing timelines, it anticipates the drug will be available through select specialty pharmacies in the United States by the end of February 2015. The drug was approved two months ahead of schedule because of its potential to significantly i...

  Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus               © World Health Organization 1999 This document is not a formal publication of the World Health Organization (WHO), and all rights are reserved by the Organization. The document may, however, be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not for sale nor for use in conjunction with commercial purposes. The views expressed in documents by named authors are solely the responsibility of those authors Contents 1. Introduction 2. Definition and diagnostic criteria for diabetes mellitus and other categories of glucose intolerance 2.1 Definition 2.2 Diagnosis and diagnostic criteria 2.2.1 Diagnosis 2.2.2 Diabetes in children 2.3 Diagnostic criteria ...